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Abstract
Background: Temporal, i.e., 24-hour, weekly, and seasonal patterns in the occurrence of acute cardiovascular and
cerebrovascular events are well documented; however, little is known about temporal, especially seasonal, variation
in multiple sclerosis (MS) and its relapses. This study investigated, by means of a validated chronobiological
method, whether severe relapses of MS, ones requiring medical specialty consultation, display seasonal differences,
and whether they are linked with seasonal differences in local meteorological variables.
Results: We considered 96 consecutive patients with severe MS relapse (29 men, 67 women, mean age 38.5 ± 8.8
years), referred to the Multiple Sclerosis Center, Bellaria Hospital, Bologna, Italy, between January 1, 2007 and
December 31, 2008. Overall, we analyzed 164 relapses (56 in men, 108 in women; 115 in patients aged < 40 years,
49 in patients ≥40 years). Relapses were more frequent in May and June (12.2% each) and the least frequent in
September (3.7%). Chronobiological analysis showed a biphasic pattern (major peak in May-June, secondary peak in
November-December, p = 0.030). Analysis of monthly mean meteorological data showed a significant seasonal
pattern in ambient temperature (peak in July, p < 0.001), relative humidity (peak in January, p < 0.001), and wind
speed (peak in June, p = 0.011).
Conclusions: In this Italian setting, we found a biphasic pattern (peaks in spring and autumn) in severe MS
relapses requiring medical consultation by doctors of the MS specialty center, apparently unrelated to
meteorological variables. Confirmations of the findings on larger multi-center populations residing in different
climatic conditions are needed to further explore the potential seasonality of MS relapses and associated
environmental triggers.
Background
Several medical conditions, in particular acute cardiovas-
cular and cerebrovascular ones, exhibit prominent tem-
poral patterns, i.e., 24-hour, weekly, and seasonal
patterns in exacerbation and mortality. For example, a
seasonal pattern, characterized by an autumn-winter
excess of onset, has been recently confirmed in the Emi-
lia-Romagna region of Italy for acute myocardial infarc-
tion [1], aortic diseases [2], and transient ischemich
attack [3]. Little is known, however, about the seasonality
of many other types of diseases, especially neurological
ones, including multiple sclerosis (MS) and its relapses,
particularly in Italy. Thus, we investigated, by means of a
validated chronobiological statistical method, whether
severe relapses of MS display seasonal differences, and
whether they are associated with temporal patterns in
local meteorological variables.
Methods
Data collection
We evaluated all consecutive cases of relapse in MS
patients referred to the Multiple Sclerosis Center, Bellaria
Hospital, Bologna, Italy, between January 1, 2007 and
December 31, 2008. The study was approved by the local
ethics committee. The definition of relapse is the occur-
rence of a new neurological deficit of at least one-day’s
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any medium, provided the original work is properly cited.duration that is unrelated to any medical condition, such
as fever, that might be causal of the exacerbated MS
symptoms. We selected this definition since for clinical
purposes it is generally agreed that an attack (or relapse),
whether defined by subjective report or by objective
observation, should last at least 24 hours [4]. This defini-
tion also ensures that the event is not a pseudoattack
that might be due to change in core body temperature
with infection. Whereas reports of attacks may be pro-
vided by subjective retrospective patient narratives,
objective clinical findings of a lesion are required to
make the diagnosis of MS. Single paroxysmal episodes
(eg, a tonic spasm) do not constitute a relapse, but multi-
ple episodes occurring over not less than 24 hours do [4].
In our MS Center, every patient is eligible to undergo
a neurological evaluation within two days of a suspected
relapse, and an advertised mobile phone number is dedi-
cated to request appointments for such. Each relapse
event was checked by at least one of the neurology
investigators to ensure satisfaction of inclusion criteria.
Frequent attacks when experienced by the same patient
were considered separate relapses only when the interval
between each exceeded one month. Patients were also
categorized into two subgroups according to age (< 40
or ≥40 years). This age criterion was chosen since
relapses in MS seem to be age dependent, with most
occurring in persons between 20 and 40 years of age
[5]. Moreover, being a male and experiencing late-age
onset of MS are related to poor prognosis [6].
Each relapse was categorized into one of twelve 1-
month intervals according to the day and month of the
onset of symptoms, based on reports systematically
obtained from patients, relatives or other care-takers. In
addition, we collected data on the average monthly
ambient temperature (°C), relative humidity (%), wind
speed (m/sec), and rain precipitation (mm) using instru-
mentation manufactured by Vaisala Oyi (Helsinki, Fin-
land) and maintained by the Agenzia Regionale
Prevenzione e Ambiente (ARPA) of the Emilia-Romagna
region, Bologna, Italy (active since May 2004), located at
longitude 11.32872, latitude 44.500752, and altitude 48
m above sea level. Meteorological measures were col-
lected daily at 13:00 h and averaged to derive the
monthly means of each variable.
Statistical analysis
We performed the main statistical analysis by applying
partial Fourier series with up to four harmonics (Chrono-
lab, free download at: http://www.tsc.uvigo.es/BIO/) [7]
to the time series of total MS cases, subgroups categor-
ized by sex and age (< 40 and ≥40 years), and each
meteorological variable. This method of analysis selects
the harmonic (or the combination of harmonics) that
best explain the variance of the time series data. The
percentage of the overall variability of the data about the
arithmetic mean attributable to the approximated cosine
curve of a given period by the method of least squares)
estimates the goodness of fit of the model, and the F-test
statistic serves to test the zero-amplitude null hypothesis
(absence of periodicity). The parameters calculated for
the overall one-year in period (i.e., 8.766-hour) cosine
approximation of the time series are: the “percentage of
rhythm” (PR) - percentage of overall variability of data
about the arithmetic mean attributable to the fitted rhyt-
mic function; the midline estimated statistic of rhythm
(MESOR) - here the rhythm-adjusted annual mean;
amplitude - one half the difference between the absolute
maximum and minimum of the fitted curve; and the
peak time (acrophase) of the occurrence of the absolute
maximum value during the year expressed in degrees
(360° = 365 years or 1 day = 0.9863°) as a negative value
from the zero-time reference, midnight December 31.
Significance levels were assumed for p < 0.05.
Results
Overall, we considered 96 patients (29 men, 67 women,
mean age 38.5 ± 8.8 years), who experienced in total
164 relapses (56 in men, 108 in women; 115 in persons
aged < 40 years, 49 in persons aged ≥40 years). In the
absence of any specific temporal patterning of relapses,
8.33% of the total number of cases would be expected
to occur each month of the year. As shown in
Figure 1-a, the distribution by month of the relapses for
the entire group was highest in May and June (12.2%
each) and the lowest in September (3.7%). Time series
analysis (Table 1) yielded a cyclic biphasic pattern, char-
acterized by a major peak in MS in May and a second-
ary peak in November (p = 0.03). Older patients (≥40
years of age) exhibited the same temporal pattern (p =
0.025), whereas younger patients showed only a non-sta-
tistically significant singled peak (may) seasonal trend (p
= 0.065). No significant periodicity was found in sub-
groups categorized by sex. The time series analysis of
meteorological variables (Table 1) revealed significant
seasonal variation with respective peaks in July for ambi-
ent temperature (Figure 1-1b, p <0 . 0 0 1 ) ,i nJ a n u a r yf o r
relative humidity (Figure 1-1c, p < 0.001), and in June
for wind speed (Figure 1-1d, p = 0.011). Rain precipita-
tion did not exhibit any significant seasonal variation.
Discussion
In this Italian setting (Bologna, Emilia-Romagna region),
we found a seasonal pattern for MS relapses, apparently
unrelated to meteorological variables, characterized by
biphasic spring-autumn peaks (main peak in May, sec-
ondary peak in November) and summer trough, espe-
cially in older (≥40 years) patients, and a trend for a
single peak in May in younger subjects.
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association between month of birth and the risk of later
developing of MS have been documented in studies con-
ducted in Canada, Great Britain, Denmark and Sweden
[8,9], with persons born in May [8] and June [9] exhibit-
ing significantly increased risk of MS.
Multiple sclerosis is an inflammatory demyelinating
disease of the central nervous system of unknown
pathogenesis, although environmental [10], genetic [11],
infectious [12], toxic [13], nutritional [14], hormonal
[15], and venous vascular [16] factors have been studied
as plausible risk factors. Moreover, exposure to ionizing
radiation [17], and organic solvents [18], including vola-
tile anaesthetic agents [19], may constitute additional
risk factors. Thus, the disparate expression of the dis-
ease itself, characterized either by a chronic progressive
or a relapsing/remitting clinical picture, perhaps helps
to explain differences between the available data on its
seasonal variation. Environmental factors that can
potentially play a role in risk of MS development or
progression include viral infections (cytokines?) and
vitamin D levels (sun exposure?), both of which exhibit
seasonal variation [20,21].
Ogawa et al. [22] observed that relapses of MS patients
were significantly more frequent in the warmest and
coldest months of the year. Stewart et al. [23] observed
that untreated MS (relapsing/remitting) cases showed a
summer excess of interleukin-10, and Balashov et al. [24]
reported a significantly increased interferon production
in the autumn and winter compared to the spring and
summer in chronic progressive MS, with maximum
values of T-cell activation (assessed in terms of tumor
necrosis factor and interferon levels) found during
autumn by Killestein et al. [25]. A population-based
study conducted in Southern Tasmania [26] detected an
inverse association between MS relapse rate and erythe-
mal ultraviolet radiation (EUV) and vitamin D [25(OH)
D] levels, suggesting a role of EUV exposure.
Figure 1 Frequency of relapses of multiple sclerosis by month of the year (a) and average monthly data of ambient temperature in °C
(b), relative humidity as % (c), and wind speed as m/sec (d).
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of relapsing MS has been reported as well. A large Por-
tuguese retrospective study of relapsing/remitting
patients (414 relapses occurring in 249 consecutive
patients studied between January 1, 2004 and December
31, 2007) [27 found no significant differences between
months or seasons, and no correlation between relapse
frequency and weather factors, including maximum and
minimum temperature, humidity, and atmospheric pres-
sure. The results of a 3-year Israeli study (2001-2003) of
235 patients [28] also found no significant correlation
between number of relapses and season or month, and
no significant impact of meteorological parameters on
relapses. On the other hand, a strong seasonal pattern
in subclinical MS activity was found in the United States
by Meier et al. [29], who investigated the seasonal pre-
valence of MS disease activity in terms of appearance of
new lesions found in serial T2-weighted MRI (n = 939
separate MRI examinations) of a cohort of 44 untreated
patients. They also tested for associations of seasonality
with recorded meteorologic data, i.e., ambient tempera-
ture, solar radiation and precipitation, in the Boston
vicinity between1991-1993 when the MRI examinations
were made. The likelihood of new T2 activity was 2-3
times higher between the months of March-August than
during the other months of the year, with a strong cor-
relation with solar radiation and with disease intensity
being elevated during the summer season.
Conclusions
Even with its evident limitations, i.e., single-center set-
ting, limited population size, and relatively small number
of events, to the best of our knowledge, this is the first
study to utilize methods specific to the field of medical
chronobiology to explore the seasonality of MS patho-
physiology. The possible relationships between seasons
and environmental factors deserve further exploration on
larger multi-center populations residing in different cli-
m a t e s .F u r t h e r m o r e ,t h er o l ep l a y e db ye n v i r o n m e n t a l
factors and endogenous human biological rhythms
requires more-in-depth investigation, since it is plausible
that seasonal variation of immune status [30] and respon-
siveness might play a role as well. It is suggestive, in fact,
that MS and allergic respiratory diseases exhibit an
Table 1 Chronobiologic analysis of seasonal distribution of multiple sclerosis relapses, and meteorological data
N Period (hours) PR (%) MESOR ± SE Amplitude Acrophase p
Total relapses 164 8766.00 10.7 N.S.
4383.00 64.0 0.012
Overall 74.7 13.69 ± 0.83 6.42 -142° (May) 0.030
Females 108 8766.00 12.1 N.S.
4383.00 29.6 N.S.
Overall 41.7 9.01 ± 0.95 3.62 -139° N.S.
Males 56 8766.00 2.3 N.S.
4383.00 35.1 N.S.
Overall 37.4 4.68 ± 0.87 2.81 -144° N.S.
< 40 yrs 115 8766.00 2.7 N.S.
4383.00 64.9 0.021
Overall 67.6 9.60 ± 0.72 4.37 -142° (May) 0.065
≥40 yrs 49 8766.00 41.0 0.031
4383.00 34.9 0.043
Overall 75.8 4.09 ± 0.26 2.11 -141° (May) 0.025
Temperature (°C) 8766.00 97.4 15.4 ± 0.39 10.05 -188.8 ± 3. 2 (July) < 0.001
Humidity (%) 8766.00 81.2 61.0 ± 1.65 14.57 -3.3 ± 9.2 (January) < 0.001
Wind speed (m/sec) 8766.00 63.1 2.20 ± 0.11 0.63 -164.7 ± 14.6 (June) 0.011
Rain precipitation (mm) 8766.00 0.7 1.81 ± 0.47 0.17 -20.8 ± 227.1 N.S.
Abbreviations (see text for details) derived by Cosinor analysis of the time series data: PR : percentage of rhythm - MESOR: midline estimated statistic of rhythm
(the rhythm-adjusted mean over the time period analyzed, i.e., the monthly mean for a cycle of one year) - Amplitude: one-half the difference between the
absolute maximum and minimum of the fitted curve - Acrophase: the absolute time of the peak expressed in degrees, with 360° = 12 months or 1 day = 0.9863,
as a negative value (i.e., a delay) in reference to midnight December 31. P value derived by the F-test statistic of the null hypothesis that the amplitude of the
fitted cosine approximation of a given period = 0
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Page 4 of 6inverse relationship, with MS tending to be less severe
when associated with allergic respiratory diseases [31].
Finally, recent findings on seasonal variation in MS lesion
activity as determined by MRI examination indicate that
future clinical trials should include such assessments in
their design along with serial measurements of those
environmental factors associated in previously conducted
studies with seasonal patterns in MS [32].
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